Clinical trials
Cardiovascular Diseases trials in Taiwan with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Recruiting | 6 |
| Active, not recruiting | 4 |
| Unknown status | 4 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Taiwan University Hospital | 5 |
| Buddhist Tzu Chi General Hospital | 2 |
| National Defense Medical Center, Taiwan | 2 |
| National Taiwan Sport University | 2 |
| National Yang Ming Chiao Tung University | 2 |
| Abbott Medical Devices | 1 |
| Academia Sinica, Taiwan | 1 |
| AstraZeneca | 1 |
| B. Braun Medical Industries Sdn. Bhd. | 1 |
| Boston Scientific Corporation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiovascular Diseases | 32 |
| Stroke | 4 |
| Coronary Artery Disease | 3 |
| Heart Diseases | 3 |
| Myocardial Ischemia | 3 |
| Acute Coronary Syndrome | 2 |
| Atherosclerosis | 2 |
| Cerebrovascular Disorders | 2 |
| Coronary Disease | 2 |
| Coronary Stenosis | 2 |
Trials
Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.